Cargando…

The humoral response to SARS-COV-2 vaccines in MS patients: A case series exploring the impact of DMT, lymphocyte count, immunoglobulins, and vaccine type

BACKGROUND & OBJECTIVES: Certain disease modifying therapies may negatively impact the humoral response to SARS-CoV-2 vaccines. Many MS related clinical, demographic, and immunological characteristics can also affect vaccine response but those have not been fully explored. This study aimed to in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jakubecz, Collin, Zhang, Xiaochun Susan, Woodson, Sophia, Serra, Alessandro, Abboud, Hesham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963970/ https://www.ncbi.nlm.nih.gov/pubmed/35381535 http://dx.doi.org/10.1016/j.msard.2022.103785

Ejemplares similares

Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination
por: Zheng, Crystal, et al.
Publicado: (2020)

COVID‐19 clinical outcomes and DMT of MS patients and population‐based controls
por: Longinetti, Elisa, et al.
Publicado: (2022)

Anti-SARS-CoV-2 antibodies following vaccination are associated with lymphocyte count and serum immunoglobulins in SLE
por: Reynolds, John A, et al.
Publicado: (2023)

Enhanced immunogenicity of the tuberculosis subunit Rv0572c vaccine delivered in DMT liposome adjuvant as a BCG-booster
por: Mao, Lirong, et al.
Publicado: (2022)

Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT
por: Barker, Steven A.
Publicado: (2022)

Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in Australia
por: Seery, Nabil, et al.
Publicado: (2020)

Humoral Immune Response to SARS-CoV-2 Vaccination in MS Patients
por: Oreja-Guevara, Celia, et al.
Publicado: (2022)

Humoral Immunity in Arsenic-Exposed Children in Rural Bangladesh: Total Immunoglobulins and Vaccine-Specific Antibodies
por: Raqib, Rubhana, et al.
Publicado: (2017)

DMT Models the Near-Death Experience
por: Timmermann, Christopher, et al.
Publicado: (2018)

DMT alters cortical travelling waves
por: Alamia, Andrea, et al.
Publicado: (2020)

Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia
por: Mustafa, S. Shahzad, et al.
Publicado: (2021)

Antigen-specific immunoglobulin variable region sequencing measures humoral immune response to vaccination in the equine neonate
por: Tallmadge, Rebecca L., et al.
Publicado: (2017)

Regulation of DMT1 on autophagy and apoptosis in osteoblast
por: Liu, Fei, et al.
Publicado: (2017)

Correction: DMT alters cortical travelling waves
por: Alamia, Andrea, et al.
Publicado: (2020)

Differential Immunogenicity and Protective Efficacy Elicited by MTO- and DMT-Adjuvanted CMFO Subunit Vaccines against Mycobacterium tuberculosis Infection
por: Ullah, Nadeem, et al.
Publicado: (2020)

Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients
por: Kelly, Hannah, et al.
Publicado: (2021)

Neural correlates of the DMT experience assessed with multivariate EEG
por: Timmermann, Christopher, et al.
Publicado: (2019)

Neural network models for DMT-induced visual hallucinations
por: Schartner, Michael M, et al.
Publicado: (2020)

CPT—DMT Correlations on Regional Soils from Croatia
por: Grabar, Kristijan, et al.
Publicado: (2022)

A qualitative study assessing patient perspectives in the process of decision-making on disease modifying therapies (DMT’s) in multiple sclerosis (MS)
por: de Ceuninck van Capelle, Archibald, et al.
Publicado: (2017)

Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomes
por: Holroyd, Kathryn B., et al.
Publicado: (2022)

Vaccination to gain humoral immune memory
por: Sarkander, Jana, et al.
Publicado: (2016)

The Humoral Immune Response to BCG Vaccination
por: Tanner, Rachel, et al.
Publicado: (2019)

Cellular and humoral immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia
por: Lyski, Zoe L., et al.
Publicado: (2022)

Diminished humoral and cellular responses to SARS-CoV-2 vaccines in patients with chronic lymphocytic leukemia
por: Ujjani, Chaitra, et al.
Publicado: (2022)

Effect of Lymphocyte Phenotypic Alterations on the Humoral Response to Vaccination Against SARS-COV-2 in Dialysis Patients
por: Lioulios, Georgios, et al.
Publicado: (2023)

Regulation of DMT1 on Bone Microstructure in Type 2 Diabetes
por: Zhang, Wei-Lin, et al.
Publicado: (2015)

Stability Evaluation of DMT and Harmala Alkaloids in Ayahuasca Tea Samples
por: de Oliveira Silveira, Gabriela, et al.
Publicado: (2020)

A narrative synthesis of research with 5-MeO-DMT
por: Ermakova, Anna O, et al.
Publicado: (2021)

Lymphocyte counts and infection rates: Long-term fingolimod treatment in primary progressive MS
por: Fox, Edward J., et al.
Publicado: (2019)

Effects of the age of vaccination on the humoral responses to a human papillomavirus vaccine
por: Nicoli, Francesco, et al.
Publicado: (2022)

Longitudinal humoral response after SARS-CoV-2 vaccination in ocrelizumab treated MS patients: To wait and repopulate?
por: van Kempen, Z.L.E., et al.
Publicado: (2022)

Sex differences in vaccine-induced humoral immunity
por: Fischinger, Stephanie, et al.
Publicado: (2018)

Dimethyltryptamine (DMT): a biochemical Swiss Army knife in neuroinflammation and neuroprotection?
por: Szabo, Attila, et al.
Publicado: (2016)

DMT1 Expression and Iron Levels at the Crossroads Between Aging and Neurodegeneration
por: Ingrassia, Rosaria, et al.
Publicado: (2019)

The fumarate salts of the N-isopropyl-N-methyl derivatives of DMT and psilocin
por: Chadeayne, Andrew R., et al.
Publicado: (2019)

Biosynthesis and Extracellular Concentrations of N,N-dimethyltryptamine (DMT) in Mammalian Brain
por: Dean, Jon G., et al.
Publicado: (2019)

Synthesis and Characterization of 5-MeO-DMT Succinate for Clinical Use
por: Sherwood, Alexander M., et al.
Publicado: (2020)

Human brain effects of DMT assessed via EEG-fMRI
por: Timmermann, Christopher, et al.
Publicado: (2023)

Dog bite, immunoglobulin, and preexposure vaccination
por: Pokee, Nora, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_spqncvec28be092j49v33spto5